Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2024-10-31 5:44 pm Sale | 13G | APYX MED CORP COM APYX | Archon Capital Management LLC | 3,115,281 8.990% | -336,749 (-9.76%) | View |
2024-10-15 09:18 am Purchase | 13G | APYX MED CORP COM APYX | ROYCE & ASSOCIATES LP | 2,582,490 7.450% | 423,590 (+19.62%) | View |
2024-05-09 07:45 am Unchanged | 13D | APYX MED CORP COM APYX | Vizirgianakis Stavros G. | 1,746,191 5.040% | 0 (Unchanged) | View |
2024-04-05 09:00 am Unchanged | 13D | APYX MED CORP COM APYX | Archon Capital Management LLC | 3,452,030 9.960% | 0 (Unchanged) | View |
2024-04-01 4:15 pm Purchase | 13D | APYX MED CORP COM APYX | Vizirgianakis Stavros G. | 1,746,191 5.040% | 1,746,191 (New Position) | View |
2024-03-25 9:52 pm Sale | 13G | APYX MED CORP COM APYX | HIRSCHMAN ORIN | 0 0.000% | -2,040,540 (Position Closed) | View |
2024-02-14 5:06 pm Sale | 13G | APYX MED CORP COM APYX | PURA VIDA INVESTMENTS LLC | 80,000 0.230% | -2,207,560 (-96.50%) | View |
2024-02-14 3:05 pm Sale | 13G | APYX MED CORP COM APYX | Divisadero Street Capital Management LP | 0 0.000% | -2,056,799 (Position Closed) | View |
2024-02-14 07:32 am Sale | 13G | APYX MED CORP COM APYX | RTW INVESTMENTS LP | 1,025,963 3.000% | -2,372,316 (-69.81%) | View |
2024-02-13 10:58 am Unchanged | 13G | APYX MED CORP COM APYX | Archon Capital Management LLC | 3,452,030 9.960% | 0 (Unchanged) | View |
2024-02-07 6:55 pm Purchase | 13G | APYX MED CORP COM APYX | HIRSCHMAN ORIN | 2,040,540 5.900% | 156,259 (+8.29%) | View |
2024-02-02 11:56 am Sale | 13G | APYX MED CORP COM APYX | Cowen Financial Products LLC | 0 0.000% | -1,775,793 (Position Closed) | View |
2024-01-23 09:52 am Unchanged | 13G | APYX MED CORP COM APYX | ROYCE & ASSOCIATES LP | 2,158,900 6.230% | 0 (Unchanged) | View |
2024-01-23 09:49 am Purchase | 13G | APYX MED CORP COM APYX | ROYCE & ASSOCIATES LP | 2,158,900 6.230% | 2,158,900 (New Position) | View |
2023-08-14 08:00 am Purchase | 13G | APYX MED CORP COM APYX | HIRSCHMAN ORIN | 1,884,281 5.400% | 197,805 (+11.73%) | View |
2023-06-12 8:59 pm Sale | 13G | APYX MED CORP COM APYX | HIRSCHMAN ORIN | 1,686,476 4.900% | -309,524 (-15.51%) | View |
2023-05-19 5:17 pm Purchase | 13G | APYX MED CORP COM APYX | Divisadero Street Capital Management LP | 2,056,799 5.900% | 2,056,799 (New Position) | View |
2023-05-12 06:42 am Purchase | 13G | APYX MED CORP COM APYX | HIRSCHMAN ORIN | 1,996,000 5.800% | 1,996,000 (New Position) | View |
2023-02-14 2:45 pm Sale | 13G | APYX MED CORP COM APYX | PURA VIDA INVESTMENTS LLC | 2,287,560 6.610% | -207,877 (-8.33%) | View |
2023-02-13 2:06 pm Unchanged | 13G | APYX MED CORP COM APYX | Archon Capital Management LLC | 3,452,030 9.980% | 0 (Unchanged) | View |